RxDoctor Payments Data

Ana Lince, MD

Psychiatry · Alexandria, VANPI 1962571646

Payments from drug & device makers

$1,749in general payments, 2019–2025

Across 84 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$421
  • Otsuka America Pharmaceutical, Inc.$294
  • Teva Pharmaceuticals USA, Inc.$291
  • Johnson & Johnson$202
  • Alkermes, Inc.$158
  • AbbVie$105
  • plus $277 from 6 others

What the payments were for

  • Food & beverage$1,62293%
  • Education$1277%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,749 in reported general payments places this provider in the 80th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia

Medicare billing

Part B allowed, 2024
$8,017
Medicare patients
14
Services billed
55

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine18$125,416
Invega SustennaPaliperidone Palmitate27$90,194
VraylarCariprazine Hcl14$24,771
BelsomraSuvorexant19$8,159
Lurasidone Hcl16$6,400
Clozapine77$3,280
Aripiprazole23$1,602
Risperidone68$785
Duloxetine Hcl33$623
Olanzapine12$467
Quetiapine Fumarate43$457
Bupropion Hcl SrBupropion Hcl12$417
Mirtazapine22$384
Hydroxyzine Hcl13$376
Benztropine Mesylate26$354

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$291$125,41618 claims
Johnson & JohnsonInvega Sustenna$202$90,19427 claims
AbbVieVraylar$105$24,77114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →